Cargando…
Survival of patients with deficient mismatch repair metastatic colorectal cancer in the pre-immunotherapy era
BACKGROUND: Metastatic colorectal cancer patients with deficient mismatch repair (dMMR mCRC) benefit from immunotherapy. Interpretation of the single-arm immunotherapy trials is complicated by insignificant survival data during systemic non-immunotherapy. We present survival data on a large, compreh...
Ejemplares similares
-
Physical Activity Is Associated with Improved Overall Survival among Patients with Metastatic Colorectal Cancer
por: Smit, Karel C., et al.
Publicado: (2022) -
Survival of Patients with Deficient Mismatch Repair Versus Proficient Mismatch Repair Metastatic Colorectal Cancer Receiving Curative-Intent Local Treatment of Metastases in a Nationwide Cohort
por: Zwart, Koen, et al.
Publicado: (2023) -
Prospective Volumetric Assessment of the Liver on a Personal Computer by Nonradiologists Prior to Partial Hepatectomy
por: Dello, Simon A. W. G., et al.
Publicado: (2010) -
Concepts of health in different contexts: a scoping review
por: van Druten, V. P., et al.
Publicado: (2022) -
Nuclear positioning rather than contraction controls ordered rearrangements of immunoglobulin loci
por: Rother, Magdalena B., et al.
Publicado: (2016)